News

Deal Announcements

Celsense Gets More Seed Funding For Product

Wednesday, August 15, 2007 5:00:00 AM PDT | VentureDeal Staff
PITTSBURGH, PA -- Biotechnology company Celsense has received $100,000 in seed funding for further development of its cell imaging technology.

Celsense is working on products that enable real-time in vivo imaging of transplanted cells for therapeutic and diagnostic purposes, all while using conventional MRI equipment.

Pittsburgh Life Sciences Greenhouse invested the funds as part of several companies receiving investments.  The company has already secured in excess of $1.3 million in venture equity investment.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1